Your browser doesn't support javascript.
loading
Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection.
Noel, Alan R; Bowker, Karen E; Attwood, Marie; MacGowan, Alasdair P.
  • Noel AR; Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Infection Sciences, Pathology Sciences Building Phase 2, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
  • Bowker KE; Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Infection Sciences, Pathology Sciences Building Phase 2, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
  • Attwood M; Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Infection Sciences, Pathology Sciences Building Phase 2, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
  • MacGowan AP; Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Infection Sciences, Pathology Sciences Building Phase 2, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
J Antimicrob Chemother ; 73(9): 2411-2417, 2018 09 01.
Article en En | MEDLINE | ID: mdl-30020472

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Amicacina / Cefalosporinas / Infecciones por Bacterias Gramnegativas / Inhibidores de beta-Lactamasas / Tazobactam / Bacterias Gramnegativas / Antibacterianos Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Amicacina / Cefalosporinas / Infecciones por Bacterias Gramnegativas / Inhibidores de beta-Lactamasas / Tazobactam / Bacterias Gramnegativas / Antibacterianos Idioma: En Año: 2018 Tipo del documento: Article